vimarsana.com

Latest Breaking News On - Amarin company profile - Page 1 : vimarsana.com

Zacks Research Comments on Amarin Co plc s Q3 2024 Earnings (NASDAQ:AMRN)

Amarin Co. plc (NASDAQ:AMRN – Free Report) – Investment analysts at Zacks Research lowered their Q3 2024 earnings per share estimates for shares of Amarin in a research report issued to clients and investors on Wednesday, May 15th. Zacks Research analyst R. Department now expects that the biopharmaceutical company will post earnings of ($0.06) per […]

Amarin (NASDAQ:AMRN) Posts Quarterly Earnings Results, Beats Expectations By $0 02 EPS

Amarin (NASDAQ:AMRN – Get Free Report) released its earnings results on Wednesday. The biopharmaceutical company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.02, Yahoo Finance reports. Amarin had a negative net margin of 19.26% and a negative return on equity of 10.47%. The company had revenue […]

Amarin Co plc (NASDAQ:AMRN) Short Interest Update

Amarin Co. plc (NASDAQ:AMRN – Get Free Report) was the target of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 15,840,000 shares, a decrease of 12.1% from the March 31st total of 18,020,000 shares. Based on an average trading volume of 1,680,000 shares, […]

Q1 2024 EPS Estimates for Amarin Co plc Boosted by Zacks Research (NASDAQ:AMRN)

Amarin Co. plc (NASDAQ:AMRN – Free Report) – Equities researchers at Zacks Research raised their Q1 2024 earnings per share (EPS) estimates for Amarin in a research note issued to investors on Thursday, March 21st. Zacks Research analyst R. Department now forecasts that the biopharmaceutical company will earn ($0.04) per share for the quarter, up […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.